Translational Immunology Group at @ChariteBerlin and @berlinnovation. Posts by lab members.
Berlin, Germany
Joined December 2022
- Tweets36
- Following58
- Followers173
- Likes59
Very exciting week for Sawitzki Lab! 🎉 We’ve moved into brand-new lab spaces at the Rahel Hirsch Center for Translational Medicine (BIH & Charité).
Plus, we’ve made the leap to Bluesky where you will find us under the same handle! 🚀
Why does age make COVID-19 more dangerous? Our latest study shows molecular shifts with age, revealing how changes in immune signaling drive enhanced inflammation across the immune cell landscape.
biorxiv.org/content/10.1101/…
We analyzed patients who had type I IFN autoantibodies. They showed the most extreme phenotype. We even detected similar shift in signaling in young (ISGs) and adult hamsters (S100A genes) infected with COVID-19, suggesting that we discovered a general aging-induced concept.
A great collaborative effort by Birgit Sawitzki, Lev Petrov, @woodernrobo, Sophia Brumhard, Philipp Georg @phige21, Anna Hiller, Leif Erik Sander @Sander_Lab, Nils Blüthgen @molsysbio, @RalserLab, @ewyler, @robuelow, @rosasta_g and many others!
Sawitzki Lab retweeted
Don´t forget to register for the Berlin-wide Immunology & Inflammation Symposium 2024 on Oct 7, at Charité Campus Mitte
Registration and abstract submission deadline is extended until Sep 12!
bit.ly/4dDWu84
DRFZ on behalf of the organization committee
Sawitzki Lab retweeted
Can single-cell omics enhance clinical studies?
Find out @CellCellPress 👀cell.com/cell/fulltext/S0092… about the potential of single-cell omics for monitoring in vivo target engagement of immunomodulatory drugs and for patient stratification for precision medicine approaches.
[1/8]
Sawitzki Lab retweeted
Dexamethasone, a cheap and widely available drug, saved millions of lives during the COVID-19 pandemic.
Our teams @chariteBerlin @berlinnovation and @dzne_en have now decoded the mechanism underlying its life-saving benefit in severe COVID-19.
cell.com/cell/fulltext/S0092…
New review spearheaded by Anne Noom and Georg Duda on the importance of cellular metabolism in myofibroblast contraction is out now! ⬇️
nature.com/articles/s41536-0…
We’re excuted to have you join our team, @Lucas_Arendholz!
This Post is from an account that no longer exists. Learn more
📢 Open PhD Position in Sawitzki Lab📢
We are looking for a PhD candidate to study severe immunopathologies using both wet lab and bioinformatics techniques.
Apply by April 3rd 2024! 👇 #PhDposition
jobs.bihealth.org/PhD-studen…
Sawitzki Lab retweeted
Biomarker, diagnostic studies and clinical trials
The #NKSG is conducting in-depth analysis of potential biomarkers and diagnostics for both #LongCovid and #MECFS.
In addition, 5 treatment trials are expected to conclude by the end of 2024. More trials are currently in planning.
Sawitzki Lab retweeted
NKSG website now available in English
Details on the National Clinical Studies Group (#NKSG) for #MECFS & #LongCovid are now available in English: cfc.charite.de/en/clinical_r…
@BMBF_Bund has been funding the group with €10m since late 2022, with another €8m approved for 2025-26.
📢We are looking for a highly motivated PhD student to join our lab in Berlin within an EU doctoral network!
Topic: Cross-tissue organoid immune cell integration and function.
Deadline: November 30th, 2023.
More info: topgut.eu/.
#PhDPosition #MSCA #Immunology